drugset / Trial / NCT04296799
A Phase 1 Study of SMP-100 in Normal Healthy Volunteers
RandomizedSequentialDouble-blindTreatment
Summary
This will be the first clinical study of oral administration SMP-100 in healthy subjects. The proposed randomized Phase 1 trial is a double-blind, placebo-controlled, single and multiple ascending dose study in approximately 72 healthy male and female subjects.
Timeline
- Start
- 2020-06-25
- Primary completion
- 2021-07-26
- Completion
- 2021-08-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SMP-100 | Other / unclassified | — | Oral |
Indications
No indication recorded.